Complaint of insomnia as a predictor of aging symptoms in males at a men’s health clinic

References

• Amore M. Partial androgen deficiency and neuropsychiatric symptoms in aging men. J Endocrinol Invest 2005;28:49–54.
   PubMedGoogle Scholar
• Sato Y, Kato S, Ohnishi S, Nakajima H, Nanbu A, Nitta T, Koroku M, et al. [Analysis of clinical manifestations and endocrinological aspects of patients having PADAM-like symptoms]. Nippon Hinyokika Gakkai Zasshi 2004;95:8–16.
   PubMedGoogle Scholar
• Heinemann LA, Zimmermann T, Vermeulen A, Thiel C. A new ‘aging males’ symptoms’ (AMS) rating scale. Aging Male 1999;2:105–114.
   Google Scholar
• Chen CY, Wang WS, Liu CY, Lee SH. Reliability and validation of a Chinese version of the Aging Males’ Symptoms scale. Psychol Rep 2007;101:27–38.
   PubMed Web of Science ®Google Scholar
• Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, et al. The Aging Males’ Symptoms (AMS) scale: Review of its methodological characteristics. Health Qual Life Outcomes 2003;1:77.
   PubMedGoogle Scholar
• Heinemann LA, Saad F, Thiele K, Wood-Dauphinee S. The aging males’ symptoms (AMS) rating scale: Cultural and linguistic validation into English. Aging Male 2001;4:14–22.
   Google Scholar
• Heinemann LA, Saad F, Pöllänen P. Measurement of quality of life specific for aging males. In: Schneider HPG (Ed.). Hormone Replacement Therapy and Quality of Life. Parthenon Publishing Group. London, New York, Washington. 2002; pp. 63–83.
   Google Scholar
• Myon E, Martin N, Taïeb C, Heinemann LA. Experiences with the French Aging Males’ Symptoms (AMS) scale. Aging Male 2005;8:184–189.
   PubMedGoogle Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its complications for policy and intervention strategies. Lancet 2004;363:157–163.
   PubMed Web of Science ®Google Scholar
• Education Weekly News (in Chinese) [Internet]. Department of Health, Executive Yuan, R.O.C. (Taiwan); 2002 Apr 15–[cited 2002 Aug 19]; Available from:http://www.doh.gov.tw/CHT2006/DM/SEARCH_RESULT.aspx.
   Google Scholar
• Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM 3rd. Validation of a screening questionnaire for androgen deficiency in aging males. Metab Clin Exp 2000;49:1239–1242.
   PubMed Web of Science ®Google Scholar
• Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. 1996. Manual for the Beck depression inventory-II. San Antonio, TX: Psychological Corporation.
   Google Scholar
• Lu ML, Che HH, Chang SW, Shen WT. Reliability and validation of Chinese version of the Beck depression inventory-II (Article in Chinese). Formosan J Med 2002;16:301–310.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893–897.
   PubMed Web of Science ®Google Scholar
• Che HH, Lu ML, Chen HC, Chang SW, Li YC. Reliability and validation of Chinese version of the Beck anxiety inventory (Article in Chinese). Formosan J Med 2006;10:447–454.
   Google Scholar
• Ichioka K, Nishiyama H, Yoshimura K, Itoh N, Okubo K, Terai A. Aging Males’ Symptoms scale in Japanese men attending a multiphasic health screening clinic. Urology 2006;67:589–593.
   PubMed Web of Science ®Google Scholar
• Amore M, Scarlatti F, Quarta AL, Tagariello P. Partial androgen deficiency, depression and testosterone treatment in aging men. Aging Clin Exp Res 2009;21:1–8.
   PubMed Web of Science ®Google Scholar
• Yoshida NM, Kumano H, Kuboki T. Does the Aging Males’ Symptoms scale assess major depressive disorder?: A pilot study. Maturitas 2006;53:171–175.
   PubMed Web of Science ®Google Scholar
• Spira AP, Friedman L, Aulakh JS, Lee T, Sheikh JI, Yesavage JA. Subclinical anxiety symptoms, sleep, and daytime dysfunction in older adults with primary insomnia. J Geriatr Psychiatry Neurol 2008;21:56–60.
   PubMedGoogle Scholar
• Spira AP, Friedman L, Flint A, Sheikh JI. Interaction of sleep disturbances and anxiety in later life: Perspectives and recommendations for future research. J Geriatr Psychiatry Neurol 2005;18:109–115.
   PubMedGoogle Scholar
• Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 2000;53:703–711.
   PubMed Web of Science ®Google Scholar
• Gallardo E, Simón C, Levy M, Guanes PP, Remohí J, Pellicer A. Effect of age on sperm fertility potential: Oocyte donation as a model. Fertil Steril 1996;66:260–264.
   PubMed Web of Science ®Google Scholar
• Mårin P, Holmäng S, Jönsson L, Sjöström L, Kvist H, Holm G, Lindstedt G, Björntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992;16:991–997.
   PubMed Web of Science ®Google Scholar
• Tan RS, Pu SJ. Is it andropause? Recognizing androgen deficiency in aging men. Postgrad Med 2004;115:62–66.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000;57:141–7; discussion 155.
   PubMedGoogle Scholar
• Kraus MR, Schäfer A, Bentink T, Scheurlen M, Weissbrich B, Al-Taie O, Seufert J. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: Interferon-induced functional androgen deficiency or depression? J Endocrinol 2005;185:345–352.
   PubMed Web of Science ®Google Scholar
• Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006;7:200–210.
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335–4343.
   PubMed Web of Science ®Google Scholar
• Morales A, Lunenfeld B; International Society for the Study of the Aging Male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74–86.
   PubMedGoogle Scholar
• Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
   PubMed Web of Science ®Google Scholar
• Hanus M, Matousková M, Stárka L, Hill M. Hormonal homeostasis in a group of 216 aging Czech males and correlation with responses to a questionnaire of the University of St Louis. Aging Male 2006;9:103–110.
   PubMed Web of Science ®Google Scholar
• Tostain JL, Blanc F. Testosterone deficiency: A common, unrecognized syndrome. Nat Clin Pract Urol 2008;5:388–396.
   PubMedGoogle Scholar
• Tancredi A, Reginster JY, Schleich F, Pire G, Maassen P, Luyckx F, Legros JJ. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004;151:355–360.
   PubMed Web of Science ®Google Scholar
• Tan RS. Andropause: Introducing the concept of ‘relative hypogonadism’ in aging males. Int J Impot Res 2002;14:319.
   PubMedGoogle Scholar
• Heaton JP, Morales A. Andropause–a multisystem disease. Can J Urol 2001;8:1213–1222.
   PubMedGoogle Scholar
• Haren MT, Kim MJ, Tariq SH, Wittert GA, Morley JE. Andropause: A quality-of-life issue in older males. Med Clin North Am 2006;90:1005–1023.
   PubMed Web of Science ®Google Scholar